About Arokast FT 5 mg Flash Tablet
Arokast FT 5 mg flash tablet is a medicine made by Navana Pharmaceuticals Ltd. Montelukast Sodium is indicated for: Prophylaxis and chronic treatment of asthma Acute prevention of Exercise-Induced Bronchoconstriction (EIB) Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis Your doctor will decide if it is suitable for you.
There are 35 brands of Montelukast Sodium listed in Bangladesh. 17 of them have a lower unit price than Arokast FT. The lowest listed price is Airway 4 mg Tablet at ৳ 6.00 per unit.
What is Arokast FT 5 mg Flash Tablet?
Arokast FT 5 mg flash tablet is a medicine made by Navana Pharmaceuticals Ltd. Montelukast Sodium is indicated for: Prophylaxis and chronic treatment of asthma Acute prevention of Exercise-Induced Bronchoconstriction (EIB) Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis Use it only as your doctor directs.
Uses of Arokast FT
Montelukast Sodium is indicated for: Prophylaxis and chronic treatment of asthma Acute prevention of Exercise-Induced Bronchoconstriction (EIB) Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis Your doctor will decide if it is suitable for you.
How to use Arokast FT
Swallow the flash tablet with water. Arokast FT is taken by mouth. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Arokast FT
Rare : Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor. Uncommon : Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders. Common : Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
There are no adequate and well-controlled studies in pregnant women. So caution should be exercised when Montelukast is given to a nursing mother. Montelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmatic. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Arokast FT prescribed?
Montelukast Sodium is indicated for: Prophylaxis and chronic treatment of asthma Acute prevention of Exercise-Induced Bronchoconstriction (EIB) Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis Your doctor will decide if it is suitable for you.
How should I take Arokast FT?
Swallow the flash tablet with water. Arokast FT is taken by mouth.
Can Arokast FT cause side effects?
Rare : Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor. Uncommon : Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.
How much does Arokast FT cost in Bangladesh?
The listed price is ৳ 9.00.
- Strength
- 5 mg
Price in Bangladesh
৳ 8.82 ৳ 9.00 2% off unit price
Price updated: 18 Nov 2026
Indications
Montelukast Sodium is indicated for:
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1). The cysteinyl leukotrienes (LTC4, LTD4, LTE4) are products of arachidonic acid metabolism and are released from various cells, including mast cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor occupation have been correlated with the pathophysiology of asthma & allergic rhinitis, including airway edema, smooth muscle contraction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.
Dosage & Administration
Adults & adolescents (15 years & older)-
- Asthma & Allergic Rhinitis: 10 mg/day
- Exercise-Induced Bronchoconstriction: 10 mg/day
Pediatric patients (6 to 14 years)-
- Asthma & Allergic Rhinitis: 5 mg/day
- Exercise-Induced Bronchoconstriction: 5 mg/day
Pediatric patients (6 months to 5 years)-
- Asthma & Allergic Rhinitis: 4 mg/day
- Exercise-Induced Bronchoconstriction: Not recommended
Patients with both asthma and allergic rhinitis should take only one dose daily in the evening. For prevention of Acute prevention of Exercise-Induced Bronchoconstriction, a single dose should be taken at least 2 hours before exercise.
Interaction
With medicine: No dose adjustment is needed when montelukast is co-administered with theophylline, prednisone, prednisolone, terfenadine, digoxin, warfarin, gemfibrozil, itraconazole, thyroid hormones, sedative-hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, decongestants, oral contraceptives, and Cytochrome P450 (CYP) enzyme inducers.
With food and others: Bioavailability and other conditions were not significantly observed with food & other conditions.
Contraindications
Montelukast is contraindicated in patients who are hypersensitive to any component of this product.
Side Effects
Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection.
Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage, irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation, sleep disorders.
Rare: Angioedema, concentration impaired, disorientation, eosinophilic granulomatosis with polyangiitis, erythema nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary eosinophilia, suicidal tendencies, tremor.
Pregnancy & Lactation
There are no adequate and well-controlled studies in pregnant women. Montelukast should be used during pregnancy only if clearly needed. Montelukast is excreted in breast milk. So caution should be exercised when Montelukast is given to a nursing mother.
Precautions & Warnings
Montelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks, including status asthmatic. Neuropsychiatric events including agitation, hostility, anxiousness, depression, disorientation, disturbance in attention, dream abnormalities, hallucinations, insomnia, irritability, memory impairment, restlessness, somnambulism, suicidal thinking and behavior (including suicide) and tremor.
Overdose Effects
There were no adverse experiences in the majority of overdosage reports. The most frequently occurring adverse experiences were consistent with the safety profile of Montelukast and included abdominal pain, somnolence, thirst, headache, vomiting and psychomotor hyperactivity. In the event of overdose, it is reasonable to employ the usual supportive measures; e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring, and institute supportive therapy, if required.
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture. Keep out of reach of children.
Alternative brands of Montelukast Sodium
Other brands with the same generic name, cheapest first.
See all 35 brands
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.